Influence of a critical single nucleotide polymorphism on nuclear receptor PXR-promoter function

被引:13
作者
Rana, Manjul [1 ]
Coshic, Poonam [2 ]
Goswami, Ravinder [3 ]
Tyagi, Rakesh K. [1 ]
机构
[1] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India
[2] All India Inst Med Sci, Dept Transfus Med, New Delhi 110029, India
[3] All India Inst Med Sci, Dept Endocrinol & Metab, New Delhi 110029, India
关键词
gene expression; IBD; promoter; PXR; single nucleotide polymorphism; PREGNANE-X-RECEPTOR; INFLAMMATORY-BOWEL-DISEASE; XENOBIOTIC RECEPTOR; GENE; IDENTIFICATION; TRANSREPRESSION; METABOLISM; VARIANTS; LOCUS; SNP;
D O I
10.1002/cbin.10744
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The Pregnane and Xenobiotic Receptor (PXR; NR1I2) is a ligand-modulated transcription factor that belongs to the nuclear receptor superfamily. It is expressed at higher levels primarily in liver and intestine as compared to the levels in several other organs. It is activated by a broad spectrum of xenobiotics and endobiotics. The primary function of PXR is to regulate the expression of drug metabolizing enzymes and transporters and prevent the accumulation of toxic chemicals in the body, thereby maintaining body's homeostasis. In this study, we identified a C/T single nucleotide polymorphism at position -831 from the transcriptional start site of the PXR gene promoter and examined the functional significance of this variant using both the luciferase reporter gene assays and electrophoretic mobility shift assays (EMSA). Transient transfection experiments showed that the T-allele was associated with significantly greater transcriptional activity than the C-allele of SNP rs3814055. These results indicate that the -831C/T polymorphism has a direct effect on transcriptional regulation of PXR gene. This allelic variation may be a potential genetic marker that can help identify individuals at higher risk for Inflammatory Bowel Disease (IBD).
引用
收藏
页码:570 / 576
页数:7
相关论文
共 36 条
  • [1] Screening for polymorphisms in the PXR gene in a Dutch population
    Bosch, TM
    Deenen, M
    Pruntel, R
    Smits, PHM
    Schellens, JHM
    Beijnen, JH
    Meijerman, I
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (05) : 395 - 399
  • [2] The essence of SNPs
    Brookes, AJ
    [J]. GENE, 1999, 234 (02) : 177 - 186
  • [3] Cecchin E, 2016, EXPERT OPIN DRUG MET, V1, P1
  • [4] Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects
    di Masi, Alessandra
    De Marinis, Elisabetta
    Ascenzi, Paolo
    Marino, Maria
    [J]. MOLECULAR ASPECTS OF MEDICINE, 2009, 30 (05) : 297 - 343
  • [5] The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease
    Dring, MM
    Goulding, CA
    Trimble, VI
    Keegan, D
    Ryan, AW
    Brophy, KM
    Smyth, CM
    Keeling, PWN
    O'Donoghue, D
    O'Sullivan, M
    O'Morain, C
    Mahmud, N
    Wikström, AC
    Kelleher, D
    McManus, R
    [J]. GASTROENTEROLOGY, 2006, 130 (02) : 341 - 348
  • [6] Peptide mimetic HIV protease inhibitors are ligands for the orphan receptor SXR
    Dussault, I
    Lin, M
    Hollister, K
    Wang, EH
    Synold, TW
    Forman, BM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (36) : 33309 - 33312
  • [7] New genes in inflammatory bowel disease: lessons for complex diseases?
    Gaya, DR
    Russell, RK
    Nimmo, ER
    Satsangi, J
    [J]. LANCET, 2006, 367 (9518) : 1271 - 1284
  • [8] Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARγ
    Ghisletti, Serena
    Huang, Wendy
    Ogawa, Sumito
    Pascual, Gabriel
    Lin, Mu-En
    Willson, Timothy M.
    Rosenfeld, Michael G.
    Glass, Christopher K.
    [J]. MOLECULAR CELL, 2007, 25 (01) : 57 - 70
  • [9] Goodwin B, 2001, MOL PHARMACOL, V60, P427
  • [10] Functional analysis of human promoter polymorphisms
    Hoogendoorn, B
    Coleman, SL
    Guy, CA
    Smith, K
    Bowen, T
    Buckland, PR
    O'Donovan, MC
    [J]. HUMAN MOLECULAR GENETICS, 2003, 12 (18) : 2249 - 2254